28 reports of this reaction
1.4% of all ACETAMINOPHEN, DEXTROMETHORPHAN HBR reports
#17 most reported adverse reaction
PYREXIA is the #17 most commonly reported adverse reaction for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, manufactured by The Procter & Gamble Manufacturing Company. There are 28 FDA adverse event reports linking ACETAMINOPHEN, DEXTROMETHORPHAN HBR to PYREXIA. This represents approximately 1.4% of all 1,934 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, DEXTROMETHORPHAN HBR who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is a less commonly reported adverse event for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, but still significant enough to appear in the safety profile.
In addition to pyrexia, the following adverse reactions have been reported for ACETAMINOPHEN, DEXTROMETHORPHAN HBR:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 28 FDA reports for ACETAMINOPHEN, DEXTROMETHORPHAN HBR. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 1.4% of all adverse event reports for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, making it a notable side effect.
If you experience pyrexia while taking ACETAMINOPHEN, DEXTROMETHORPHAN HBR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.